SPIA
BHVN

Steward Partners Investment Advisory’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Steward Partners Investment Advisory’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-23
Closed -$3K – 3537
2022
Q3 		$3K Buy
+23
New +$3.41K ﹤0.01% 2992
2020
Q1 		– Sell
-200
Closed -$10K – 2856
2019
Q4 		$10K Buy
+200
New +$9.9K ﹤0.01% 2035

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Steward Partners Investment Advisory's BHVN Position: Q4 2022 in Review

Steward Partners Investment Advisory sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 23 shares — an estimated $3K sold.

Steward Partners Investment Advisory first reported a position in BHVN in Q4 2019 and held it in 2 quarters. The position peaked at $10K in Q4 2019. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Steward Partners Investment Advisory reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 23 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $3K.
  • Steward Partners Investment Advisory first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2019 and held it in 2 quarters.
  • Steward Partners Investment Advisory's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $10K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2022, filed 15 Feb 2023.